416 related articles for article (PubMed ID: 27452340)
1. Influence of steroid hormones on ventricular repolarization.
Salem JE; Alexandre J; Bachelot A; Funck-Brentano C
Pharmacol Ther; 2016 Nov; 167():38-47. PubMed ID: 27452340
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
3. Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes.
Kurokawa J; Kodama M; Clancy CE; Furukawa T
Pharmacol Ther; 2016 Dec; 168():23-28. PubMed ID: 27595633
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
5. Drugs for men and women - how important is gender as a risk factor for TdP?
Coker SJ
Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
[TBL] [Abstract][Full Text] [Related]
6. Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.
Lazzerini PE; Cantara S; Bertolozzi I; Accioli R; Salvini V; Cartocci A; D'Errico A; Sestini F; Bisogno S; Cevenini G; Capecchi M; Laghi-Pasini F; Castagna MG; Acampa M; Boutjdir M; Capecchi PL
J Am Heart Assoc; 2022 Jan; 11(1):e023371. PubMed ID: 34935398
[TBL] [Abstract][Full Text] [Related]
7. Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration.
Abehsira G; Bachelot A; Badilini F; Koehl L; Lebot M; Favet C; Touraine P; Funck-Brentano C; Salem JE
J Clin Endocrinol Metab; 2016 Jul; 101(7):2776-84. PubMed ID: 27167057
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in autonomic modulation of ventricular repolarization in humans.
Nakagawa M; Ooie T; Ou B; Ichinose M; Takahashi N; Hara M; Yonemochi H; Saikawa T
J Cardiovasc Electrophysiol; 2005 Mar; 16(3):278-84. PubMed ID: 15817086
[TBL] [Abstract][Full Text] [Related]
9. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced QT prolongation in women during the menstrual cycle.
Rodriguez I; Kilborn MJ; Liu XK; Pezzullo JC; Woosley RL
JAMA; 2001 Mar; 285(10):1322-6. PubMed ID: 11255387
[TBL] [Abstract][Full Text] [Related]
11. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human.
Cheng J
Fundam Clin Pharmacol; 2006 Feb; 20(1):1-8. PubMed ID: 16448390
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
[TBL] [Abstract][Full Text] [Related]
13. Sex, hormones, and repolarization.
Pham TV; Rosen MR
Cardiovasc Res; 2002 Feb; 53(3):740-51. PubMed ID: 11861044
[TBL] [Abstract][Full Text] [Related]
14. Long QTc and torsades de pointes in human immunodeficiency virus disease.
Kocheril AG; Bokhari SA; Batsford WP; Sinusas AJ
Pacing Clin Electrophysiol; 1997 Nov; 20(11):2810-6. PubMed ID: 9392812
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study.
Yang PC; Kurokawa J; Furukawa T; Clancy CE
PLoS Comput Biol; 2010 Jan; 6(1):e1000658. PubMed ID: 20126530
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps.
Hreiche R; Morissette P; Turgeon J
Gend Med; 2008 Jun; 5(2):124-35. PubMed ID: 18573480
[TBL] [Abstract][Full Text] [Related]
17. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
18. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
Johansson M; Carlsson L
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
20. Non-genomic action of sex steroid hormones and cardiac repolarization.
Kurokawa J; Furukawa T
Biol Pharm Bull; 2013; 36(1):8-12. PubMed ID: 23302631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
